Movement disorders associated with aripiprazole use: a case series

scientific article published in January 2009

Movement disorders associated with aripiprazole use: a case series is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/00207450903225553
P698PubMed publication ID19916856

P2093author name stringDeborah A Hall
Pinky Agarwal
Alida Griffith
Lauren C Seeberger
Vicki Segro
P2860cites workThe antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptorQ33959664
Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disordersQ35934585
Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorderQ36708811
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar maniaQ44565868
Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experienceQ44848477
Aripiprazole and neuroleptic malignant syndromeQ45108549
P433issue12
P921main subjectmovement disordersQ2608695
P304page(s)2274-2279
P577publication date2009-01-01
P1433published inInternational Journal of NeuroscienceQ6051511
P1476titleMovement disorders associated with aripiprazole use: a case series
P478volume119